ALTERNATIVE SPLICING: TRANSCRIPTIONAL REGULATORY NETWORK IN AGROFORESTRY


Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

Abstract Single immune checkpoint blockade in advanced neuroendocrine neoplasms (NENs) shows limited efficacy; dual checkpoint blockade may improve treatment activity.Dune (NCT03095274) is a non-randomized controlled multicohort phase II clinical trial evaluating durvalumab plus tremelimumab activity COCONUT and safety in advanced NENs.This study i

read more